HIKMA PHARMACEUTICALS ORD GBP0.10HIKMA PHARMACEUTICALS ORD GBP0.10HIKMA PHARMACEUTICALS ORD GBP0.10

HIKMA PHARMACEUTICALS ORD GBP0.10

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪4.00 B‬GBP
‪152.85 M‬GBP
‪2.31 B‬GBP
‪158.10 M‬
Beta (1Y)
0.65
Employees (FY)
‪9.1 K‬
Change (1Y)
+300 +3.41%
Revenue / Employee (1Y)
‪323.55 K‬GBP
Net income / Employee (1Y)
‪21.38 K‬GBP

About HIKMA PHARMACEUTICALS ORD GBP0.10


CEO
Riad Mishlawi
Headquarters
London
Website
Founded
1978
ISIN
GB00B0LCW083
FIGI
BBG000FG1MF1
Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, Generics, and Others. The Branded segment sells branded generics and in-licensed patented products in the Middle East and North Africa. The Injectables segment includes generic injectable products distributed globally and primarily used in hospitals. The Generics segment focuses on oral and other non-injectable generic products, and is sold in the U.S. retail market. The Others segment comprises of Arab Medical Containers Ltd., International Pharmaceutical Research Center Ltd., and the chemicals division of Hikma Pharmaceuticals Ltd. (Jordan). The company was founded by Samih Taleb Darwazah in 1978 and is headquartered in London, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of HIK is 1,831 GBX — it has increased by 1.67% in the past 24 hours. Watch HIKMA PHARMACEUTICALS ORD GBP0.10 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange HIKMA PHARMACEUTICALS ORD GBP0.10 stocks are traded under the ticker HIK.
HIK stock has fallen by −0.65% compared to the previous week, the month change is a −3.93% fall, over the last year HIKMA PHARMACEUTICALS ORD GBP0.10 has showed a 4.06% increase.
We've gathered analysts' opinions on HIKMA PHARMACEUTICALS ORD GBP0.10 future price: according to them, HIK price has a max estimate of 2,752.65 GBX and a min estimate of 2,001.93 GBX. Watch HIK chart and read a more detailed HIKMA PHARMACEUTICALS ORD GBP0.10 stock forecast: see what analysts think of HIKMA PHARMACEUTICALS ORD GBP0.10 and suggest that you do with its stocks.
HIK reached its all-time high on Nov 5, 2020 with the price of 2,768 GBX, and its all-time low was 225 GBX and was reached on Nov 24, 2008. View more price dynamics on HIK chart.
See other stocks reaching their highest and lowest prices.
HIK stock is 2.33% volatile and has beta coefficient of 0.65. Track HIKMA PHARMACEUTICALS ORD GBP0.10 stock price on the chart and check out the list of the most volatile stocks — is HIKMA PHARMACEUTICALS ORD GBP0.10 there?
Today HIKMA PHARMACEUTICALS ORD GBP0.10 has the market capitalization of ‪4.06 B‬, it has decreased by −2.41% over the last week.
Yes, you can track HIKMA PHARMACEUTICALS ORD GBP0.10 financials in yearly and quarterly reports right on TradingView.
HIKMA PHARMACEUTICALS ORD GBP0.10 is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
HIKMA PHARMACEUTICALS ORD GBP0.10 revenue for the last half-year amounts to ‪1.24 B‬ GBX, despite the estimated figure of ‪1.19 B‬ GBX. In the next half-year revenue is expected to reach ‪1.18 B‬ GBX.
HIK net income for the last half-year is ‪178.69 M‬ GBP, while the previous report showed ‪47.09 M‬ GBP of net income which accounts for 279.48% change. Track more HIKMA PHARMACEUTICALS ORD GBP0.10 financial stats to get the full picture.
HIKMA PHARMACEUTICALS ORD GBP0.10 dividend yield was 3.17% in 2023, and payout ratio reached 81.97%. The year before the numbers were 2.92% and 66.56% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 9, 2024, the company has ‪9.10 K‬ employees. See our rating of the largest employees — is HIKMA PHARMACEUTICALS ORD GBP0.10 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HIKMA PHARMACEUTICALS ORD GBP0.10 EBITDA is ‪544.82 M‬ GBP, and current EBITDA margin is 23.72%. See more stats in HIKMA PHARMACEUTICALS ORD GBP0.10 financial statements.
Like other stocks, HIK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HIKMA PHARMACEUTICALS ORD GBP0.10 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HIKMA PHARMACEUTICALS ORD GBP0.10 technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HIKMA PHARMACEUTICALS ORD GBP0.10 stock shows the sell signal. See more of HIKMA PHARMACEUTICALS ORD GBP0.10 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.